These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Hardelin JP; Dodé C Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492 [TBL] [Abstract][Full Text] [Related]
4. [Molecular genetics of Kallmann syndrome: an update]. Fu C; Feng Z; Liu RZ Zhonghua Nan Ke Xue; 2011 Apr; 17(4):361-5. PubMed ID: 21548217 [TBL] [Abstract][Full Text] [Related]
5. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1. Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP J Androl; 2009; 30(1):41-5. PubMed ID: 18723471 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome. Tsai PS; Gill JC Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):160-71. PubMed ID: 16932275 [TBL] [Abstract][Full Text] [Related]
7. Kallmann syndrome in women: from genes to diagnosis and treatment. Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665 [TBL] [Abstract][Full Text] [Related]
8. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome. Leroy C; Fouveaut C; Leclercq S; Jacquemont S; Boullay HD; Lespinasse J; Delpech M; Dupont JM; Hardelin JP; Dodé C Eur J Hum Genet; 2008 Jul; 16(7):865-8. PubMed ID: 18285834 [TBL] [Abstract][Full Text] [Related]
9. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome. Kim SH; Hu Y; Cadman S; Bouloux P J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870 [TBL] [Abstract][Full Text] [Related]
10. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503 [TBL] [Abstract][Full Text] [Related]
11. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia. Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753 [TBL] [Abstract][Full Text] [Related]
12. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591 [TBL] [Abstract][Full Text] [Related]
13. Genetic insights into human isolated gonadotropin deficiency. Trarbach EB; Silveira LG; Latronico AC Pituitary; 2007; 10(4):381-91. PubMed ID: 17624596 [TBL] [Abstract][Full Text] [Related]
14. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients. Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091 [TBL] [Abstract][Full Text] [Related]
15. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism. Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984 [TBL] [Abstract][Full Text] [Related]
16. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2). Albuisson J; Pêcheux C; Carel JC; Lacombe D; Leheup B; Lapuzina P; Bouchard P; Legius E; Matthijs G; Wasniewska M; Delpech M; Young J; Hardelin JP; Dodé C Hum Mutat; 2005 Jan; 25(1):98-9. PubMed ID: 15605412 [TBL] [Abstract][Full Text] [Related]
17. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399 [TBL] [Abstract][Full Text] [Related]
19. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations. Sarfati J; Dodé C; Young J Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090 [TBL] [Abstract][Full Text] [Related]